JPMorgan Chase & Co’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.5K | Buy |
5,204
+3,176
| +157% | +$23.5K | ﹤0.01% | 5176 |
|
|
2025
Q1 | $17.5K | Sell |
2,028
-99,350
| -98% | -$855K | ﹤0.01% | 5324 |
|
|
2024
Q4 | $3.62M | Buy |
101,378
+7,324
| +8% | +$262K | ﹤0.01% | 2989 |
|
|
2024
Q3 | $4.44M | Buy |
94,054
+14,978
| +19% | +$708K | ﹤0.01% | 2709 |
|
|
2024
Q2 | $3.97M | Buy |
79,076
+21,982
| +39% | +$1.1M | ﹤0.01% | 2669 |
|
|
2024
Q1 | $6.39M | Buy |
57,094
+53,941
| +1,711% | +$6.04M | ﹤0.01% | 2410 |
|
|
2023
Q4 | $183K | Sell |
3,153
-7,528
| -70% | -$437K | ﹤0.01% | 4486 |
|
|
2023
Q3 | $339K | Sell |
10,681
-47,071
| -82% | -$1.49M | ﹤0.01% | 3934 |
|
|
2023
Q2 | $4.75M | Buy |
57,752
+52,889
| +1,088% | +$4.35M | ﹤0.01% | 2529 |
|
|
2023
Q1 | $500K | Sell |
4,863
-10,610
| -69% | -$1.09M | ﹤0.01% | 3831 |
|
|
2022
Q4 | $2.27M | Buy |
15,473
+13,068
| +543% | +$1.91M | ﹤0.01% | 2885 |
|
|
2022
Q3 | $406K | Sell |
2,405
-15,641
| -87% | -$2.64M | ﹤0.01% | 3853 |
|
|
2022
Q2 | $2.09M | Buy |
18,046
+5,661
| +46% | +$654K | ﹤0.01% | 2981 |
|
|
2022
Q1 | $1.24M | Buy |
12,385
+11,122
| +881% | +$1.11M | ﹤0.01% | 3486 |
|
|
2021
Q4 | $197K | Buy |
1,263
+2
| +0.2% | +$312 | ﹤0.01% | 4552 |
|
|
2021
Q3 | $297K | Buy |
1,261
+67
| +6% | +$15.8K | ﹤0.01% | 4222 |
|
|
2021
Q2 | $405K | Sell |
1,194
-4,493
| -79% | -$1.52M | ﹤0.01% | 4112 |
|
|
2021
Q1 | $2.3M | Sell |
5,687
-1,273
| -18% | -$515K | ﹤0.01% | 3159 |
|
|
2020
Q4 | $4.63M | Sell |
6,960
-1,335
| -16% | -$888K | ﹤0.01% | 2478 |
|
|
2020
Q3 | $3.89M | Sell |
8,295
-705
| -8% | -$331K | ﹤0.01% | 2371 |
|
|
2020
Q2 | $5.27M | Sell |
9,000
-8,867
| -50% | -$5.19M | ﹤0.01% | 2119 |
|
|
2020
Q1 | $2.6M | Sell |
17,867
-9,263
| -34% | -$1.35M | ﹤0.01% | 2426 |
|
|
2019
Q4 | $3.89M | Sell |
27,130
-10,027
| -27% | -$1.44M | ﹤0.01% | 2324 |
|
|
2019
Q3 | $1.47M | Buy |
37,157
+4,601
| +14% | +$182K | ﹤0.01% | 2883 |
|
|
2019
Q2 | $3.32M | Sell |
32,556
-379
| -1% | -$38.7K | ﹤0.01% | 2369 |
|
|
2019
Q1 | $4.33M | Buy |
32,935
+15,944
| +94% | +$2.1M | ﹤0.01% | 2181 |
|
|
2018
Q4 | $1.73M | Buy |
16,991
+4,257
| +33% | +$434K | ﹤0.01% | 2737 |
|
|
2018
Q3 | $3.18M | Buy |
12,734
+962
| +8% | +$240K | ﹤0.01% | 2518 |
|
|
2018
Q2 | $5.26M | Sell |
11,772
-555
| -5% | -$248K | ﹤0.01% | 2224 |
|
|
2018
Q1 | $4.86M | Sell |
12,327
-1,020
| -8% | -$402K | ﹤0.01% | 2229 |
|
|
2017
Q4 | $5.48M | Sell |
13,347
-67
| -0.5% | -$27.5K | ﹤0.01% | 2195 |
|
|
2017
Q3 | $5.86M | Sell |
13,414
-227
| -2% | -$99.1K | ﹤0.01% | 2088 |
|
|
2017
Q2 | $4.76M | Buy |
+13,641
| New | +$4.76M | ﹤0.01% | 2154 |
|